Product

Promitil

Aliases

Pegylated Liposomal Mitomycin-C Lipid-based Prodrug

2 clinical trials

4 indications

Indication

Indication

Gastrointestinal Intraepithelial Neoplasia

Indication

Pancreatic Cancer

Indication

Clinical trial

An Open Phase 1B Study for Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Oxaliplatin-based Chemotherapy in Patients With Gastro-intestinal Malignancies

Status: Terminated, Estimated PCD: 2023-09-10

Clinical trial

A Phase 2A Multicenter, Open Label Study of Promitil for the Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After First Line Therapy

Status: Recruiting, Estimated PCD: 2026-06-01